Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 391–405 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1124 Fibroblast Growth Factor (FGF2) Assay Test This test quantifies basic Fibroblast Growth Factor (FGF2) in plasma to assess angiogenesis and monitor tumour progression.	Plasma (Peripheral Blood)	2–3 Weeks (Monthly batch collection by 7th of month)	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Basic Fibroblast Growth Factor (FGF2)", "Angiogenic activity", "Tumour vascularisation"] Parameters [{"name": "Fibroblast Growth Factor (FGF2)", "reference_range": null}] Preparation ["A duly completed Send Out Consent Form (Form 35) is mandatory prior to collection."] Indications ["Oncology care plan management", "Monitoring anti-angiogenic therapy", "Assessing treatment resistance signals", "Gastroenterology diagnostics", "Longevity medicine assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21253-5 ICD-10: R97.8 Clinical summary This test quantifies basic Fibroblast Growth Factor (FGF2) in plasma to assess angiogenesis and monitor tumour progression.
TEST-1118 Fibromyalgia Panel Test This test evaluates multiple biomarkers including vitamins, minerals, thyroid function, inflammatory markers, and autoantibodies to aid in the assessment of fibromyalgia.	Venous Blood (Serum)	Next working day	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Vitamins (D, B12)", "Minerals (Magnesium)", "Thyroid axis", "Inflammatory markers", "Autoantibodies"] Parameters [{"name": "Vitamin D", "reference_range": null}, {"name": "Vitamin B12", "reference_range": null}, {"name": "Magnesium", "reference_range": null}, {"name": "Thyroid Hormones", "reference_range": null}, {"name": "Inflammatory Cytokines", "reference_range": null}, {"name": "Autoimmune Markers", "reference_range": null}] Preparation ["No special fasting required", "Inform phlebotomist of acute infection or severe physical trauma"] Indications ["Evaluation of potential fibromyalgia", "Exclusion of mimic disorders", "Assessment of nutritional deficiencies", "Monitoring inflammatory status"] Measurement technique Confirm with laboratory Codes LOINC: 51990-0 ICD-10: M79.7 Clinical summary This test evaluates multiple biomarkers including vitamins, minerals, thyroid function, inflammatory markers, and autoantibodies to aid in the assessment of fibromyalgia.
TEST-5215 Filaggrin (FLG) Gene Atopic Dermatitis Type 2 Genetic Test This genetic test evaluates the FLG gene for mutations associated with atopic dermatitis and related skin barrier disorders.	Peripheral whole blood (EDTA) or buccal swab	14–21 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLG gene mutations", "Skin barrier integrity"] Parameters [] Preparation [] Indications ["Diagnosis confirmation of atopic dermatitis", "Risk stratification for atopic dermatitis", "Guiding targeted therapies"] Measurement technique Confirm with laboratory Codes LOINC: 83263-0 ICD-10: L20.9, L20.8 Clinical summary This genetic test evaluates the FLG gene for mutations associated with atopic dermatitis and related skin barrier disorders.
TEST-5148 FKRP Gene (Muscular Dystrophy Type 1C) NGS Test This diagnostic test evaluates the FKRP gene for pathogenic variants associated with congenital muscular dystrophy type 1C (MDC1C) and limb-girdle muscular dystrophy 2I (LGMD2I).	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 weeks (21–28 days) from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FKRP gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Suspected congenital muscular dystrophy type 1C (MDC1C)", "Suspected limb-girdle muscular dystrophy 2I (LGMD2I)", "Family history of FKRP-related muscular dystrophy"] Measurement technique Confirm with laboratory Codes LOINC: 94268-2 ICD-10: G71.0 Clinical summary This diagnostic test evaluates the FKRP gene for pathogenic variants associated with congenital muscular dystrophy type 1C (MDC1C) and limb-girdle muscular dystrophy 2I (LGMD2I).
TEST-4371 FLNA Gene Cardiac Valvular Dysplasia, X-Linked Genetic Test This test evaluates the FLNA gene for pathogenic variants associated with X-linked cardiac valvular dysplasia.	Peripheral whole blood (3–5 mL in EDTA lavender-top tube)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene variants (SNVs, indels, CNVs)", "Pathogenic and likely pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of X-linked cardiac valvular dysplasia", "Cascade screening of at-risk family members", "Risk stratification for individuals with suspected FLNA-related heart conditions"] Measurement technique Confirm with laboratory Codes LOINC: 82993-5 ICD-10: Q24.8 Clinical summary This test evaluates the FLNA gene for pathogenic variants associated with X-linked cardiac valvular dysplasia.
TEST-4642 FLNA Gene Neuronal Intestinal Pseudo-obstruction Genetic Test This genetic test identifies pathogenic variants in the FLNA gene, which are associated with neuronal intestinal pseudo-obstruction.	Peripheral whole blood (EDTA) or DNA FTA card	3 – 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNA gene pathogenic variants", "Copy Number Variants (CNVs) in FLNA"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Clinical suspicion of neuronal intestinal pseudo-obstruction", "Family history of FLNA-related disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 101411-5 ICD-10: K59.8, Q04.5, Z13.79 Clinical summary This genetic test identifies pathogenic variants in the FLNA gene, which are associated with neuronal intestinal pseudo-obstruction.
TEST-5391 FLNB Gene Atelosteogenesis Type 1 Genetic Test This test identifies pathogenic variants in the FLNB gene associated with Atelosteogenesis Type 1 (AO1), a severe skeletal dysplasia.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FLNB gene variants", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [] Preparation ["Mandatory pre-test genetic counseling session."] Indications ["Neonatal diagnosis of skeletal dysplasia", "Carrier screening", "Familial variant tracking", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q77.3 Clinical summary This test identifies pathogenic variants in the FLNB gene associated with Atelosteogenesis Type 1 (AO1), a severe skeletal dysplasia.
TEST-5252 FLNC Gene Distal Myopathy Type 4 Genetic Test This genetic test evaluates the FLNC gene for pathogenic mutations associated with distal myopathy type 4.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic FLNC gene mutations", "Copy number variants in FLNC gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected distal myopathy type 4", "Family history of distal myopathy", "Screening of at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81268-8 ICD-10: G71.0 Clinical summary This genetic test evaluates the FLNC gene for pathogenic mutations associated with distal myopathy type 4.
TEST-4828 FLT4 Gene Hereditary Lymphedema Type 1A Genetic Test This test evaluates the FLT4 gene for pathogenic variants associated with Hereditary Lymphedema Type 1A (Milroy disease).	Peripheral Whole Blood (FTA Card also accepted)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FLT4 gene", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [{"name": "Detection & Sensitivity", "reference_range": "99.9% – includes CNVs, deep intronic variants"}] Preparation ["No specific fasting required", "Genetic counselling is mandatory prior to testing", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Diagnosis of Hereditary Lymphedema Type 1A (Milroy disease)", "Genetic counselling for families with lymphedema"] Measurement technique Confirm with laboratory Codes LOINC: 104197-1 ICD-10: Q82.0 Clinical summary This test evaluates the FLT4 gene for pathogenic variants associated with Hereditary Lymphedema Type 1A (Milroy disease).
TEST-1245 Fluoxetine Blood Test This diagnostic test evaluates the concentration of fluoxetine and its active metabolite, norfluoxetine, in the patient's serum.	Serum	2–3 weeks	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Fluoxetine", "Serum Norfluoxetine"] Parameters [{"name": "Fluoxetine", "reference_range": "Therapeutic range 120–500 ng/mL (combined with norfluoxetine)"}, {"name": "Norfluoxetine", "reference_range": "Therapeutic range 120–500 ng/mL (combined with fluoxetine)"}] Preparation ["Collect blood >12 hours after the last oral dose (trough level).", "No fasting required.", "Avoid alcohol 24 hours before collection."] Indications ["Therapeutic drug monitoring for depression, OCD, and anxiety disorders", "Dose individualization", "Assessment of adherence", "Investigation of suspected toxicity or lack of efficacy"] Measurement technique Confirm with laboratory Codes LOINC: 3573-1 ICD-10: Z79.899 Clinical summary This diagnostic test evaluates the concentration of fluoxetine and its active metabolite, norfluoxetine, in the patient's serum.
TEST-1264 FMF First Trimester Screening Test This non-invasive prenatal test evaluates the risk of common chromosomal abnormalities using biochemical markers and ultrasound findings.	Maternal Serum (SST Tube) + Ultrasound NT Data	Same-day report once ultrasound data is submitted	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Maternal serum free β-hCG", "Maternal serum PAPP-A", "Nuchal Translucency (NT) via ultrasound", "Crown-Rump Length (CRL) via ultrasound", "Nasal Bone assessment via ultrasound"] Parameters [{"name": "Free β-hCG", "reference_range": null}, {"name": "PAPP-A", "reference_range": null}, {"name": "Nuchal Translucency (NT)", "reference_range": null}, {"name": "Crown-Rump Length (CRL)", "reference_range": "45–84 mm"}, {"name": "Nasal Bone", "reference_range": "Presence/Absence"}] Preparation ["Fasting is not required", "Do not discontinue prescribed medication without consulting your referring physician"] Indications ["Pregnancy between 11 weeks and 13 weeks 6 days gestation", "Risk assessment for Trisomy 21, 18, and 13"] Measurement technique Confirm with laboratory Codes LOINC: 49091-2 ICD-10: Z36.0, Z13.71, Z36.89 Clinical summary This non-invasive prenatal test evaluates the risk of common chromosomal abnormalities using biochemical markers and ultrasound findings.
TEST-2278 FOXP2 Gene Speech-Language Disorder Type 1 Genetic Test This genetic test identifies pathogenic variants in the FOXP2 gene associated with Childhood Apraxia of Speech (CAS) and related dysmorphology.	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FOXP2 gene", "Coding regions and splice sites of the FOXP2 gene"] Parameters [] Preparation [] Indications ["Suspected Childhood Apraxia of Speech (CAS)", "Family history of FOXP2-related disorders", "Need for personalized speech therapy"] Measurement technique Confirm with laboratory Codes LOINC: 92121-8 ICD-10: F80.81, Z13.89 Clinical summary This genetic test identifies pathogenic variants in the FOXP2 gene associated with Childhood Apraxia of Speech (CAS) and related dysmorphology.
TEST-1567 Fragile X Syndrome (FMR1) Detection by PCR Test This test detects CGG repeat expansions in the FMR1 gene, which are associated with Fragile X syndrome.	Peripheral Whole Blood (EDTA)	3–4 Business Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CGG repeat expansions in the FMR1 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Fragile X syndrome", "Carrier screening", "Evaluation of intellectual disability", "Evaluation of autism spectrum disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21660-5 ICD-10: Q99.2, Z14.8 Clinical summary This test detects CGG repeat expansions in the FMR1 gene, which are associated with Fragile X syndrome.
TEST-1273 Fragile X Tremor/Ataxia Syndrome (FXTAS) Genetic Test This diagnostic test evaluates the number of CGG repeats in the FMR1 gene to identify premutation or full mutation status associated with FXTAS.	Whole blood (EDTA, Lavender Top)	4 working days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CGG trinucleotide repeat expansions in the FMR1 gene", "Premutation carrier status (55–200 repeats)", "Full mutation status (>200 repeats)"] Parameters [{"name": "FMR1 CGG Repeat Count", "reference_range": "< 55 repeats (Normal)"}] Preparation ["No specific fasting required", "Provide a full current medication list"] Indications ["Adults over 50 with progressive cerebellar ataxia and intention tremor", "Individuals with a family history suggestive of Fragile X-associated disorders", "Differential diagnosis of late-onset neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 49255-1 ICD-10: G11.1, G11.8 Clinical summary This diagnostic test evaluates the number of CGG repeats in the FMR1 gene to identify premutation or full mutation status associated with FXTAS.
TEST-3038 FREM1 Gene (Bifid Nose) Genetic Test This test identifies mutations in the FREM1 gene associated with bifid nose, a congenital craniofacial anomaly.	Peripheral whole blood (3–5 mL EDTA) or FTA card blood spot or extracted DNA	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FREM1 gene sequence variants", "Pathogenic mutations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling", "Pedigree chart (family history) required"] Indications ["Diagnosis confirmation of bifid nose", "Familial risk assessment", "Surgical planning guidance"] Measurement technique Confirm with laboratory Codes LOINC: 82321-5 ICD-10: Q30.2, Q18.8 Clinical summary This test identifies mutations in the FREM1 gene associated with bifid nose, a congenital craniofacial anomaly.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories